Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

103 (48%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PROPRANOLOL 40MG TABLET Resolved 2020-04-10 2020-05-21 111835
TEVA-PROPRANOLOL 40MG TABLET Resolved 2022-09-07 2023-01-12 168741
TEVA-PROPRANOLOL 80MG TABLET Resolved 2023-06-20 2023-07-05 195760
TEVA-PROPRANOLOL 20MG TABLET Resolved 2025-03-27 2025-04-24 253565
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-02 256462
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-21 113761
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-17 2021-01-21 130291
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-18 199554
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-04-10 250906
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-08 256465
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-12 2019-10-04 93656
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-02-06 2025-05-08 249731
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-07-05 195118
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-25 2021-04-21 136341
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-03-06 2020-05-21 107986
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-05-29 111823
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2025-04-02 2025-04-10 253963
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-07-12 194163
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
RATIO-LENOLTEC NO 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-METFORMIN 850MG TABLET Discontinued 2020-07-10 2020-07-10 120012
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97243
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97261
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917
RATIO-TOPISALIC 20MG 0.5MG LOTION Discontinued 2024-06-28 2024-06-29 231583
TEVA-ACYCLOVIR 400MG TABLET Discontinued 2025-04-29 2025-04-29 256125
TEVA-ACYCLOVIR 800MG TABLET Discontinued 2025-04-29 2025-04-29 256128
TEVA-ACYCLOVIR 200MG TABLET Discontinued 2025-04-29 2025-04-29 256122
TEVA-AMITRIPTYLINE 25MG TABLET Discontinued 2022-01-07 2022-01-07 152351
TEVA-AMITRIPTYLINE 50MG TABLET Discontinued 2022-01-07 2022-01-07 152378
TEVA-AMITRIPTYLINE 25MG TABLET Discontinued 2022-01-07 2022-01-07 152375
TEVA-AMITRIPTYLINE 10MG TABLET Discontinued 2020-09-24 2020-09-24 124896

Showing 101 to 120 of 300